Gene · 4065
Papers1,798
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,798
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. | Acta Biomater | 2021 | 34153512 | PubTator, text mining | PubMed |
| The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming. | Front Immunol | 2021 | 34149687 | PubTator, text mining | PubMed |
| Transient Expression in Cytoplasm and Apoplast of Rotavirus VP6 Protein Fused to Anti-DEC205 Antibody in Nicotiana benthamiana and Nicotiana sylvestris. | Mol Biotechnol | 2021 | 34146324 | PubTator, text mining | PubMed |
| Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition. | Mol Ther Oncolytics | 2021 | 34141869 | PubTator, text mining | PubMed |
| Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients. | Front Immunol | 2021 | 34140950 | PubTator, text mining | PubMed |
| Nanotherapeutics for treating coronavirus diseases. | J Drug Deliv Sci Technol | 2021 | 34127930 | PubTator, text mining | PubMed |
| Sustained viremia suppression by SHIVSF162P3CN-recalled effector-memory CD8+ T cells after PD1-based vaccination. | PLoS Pathog | 2021 | 34125864 | PubTator, text mining | PubMed |
| Logical modelling of in vitro differentiation of human monocytes into dendritic cells unravels novel transcriptional regulatory interactions. | Interface Focus | 2021 | 34123352 | PubTator, text mining | PubMed |
| RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first-second trimester transition. | Biol Open | 2021 | 34100896 | PubTator, text mining | PubMed |
| Development of an Immune-Related Prognostic Index Associated With Glioblastoma. | Front Neurol | 2021 | 34093386 | PubTator, text mining | PubMed |
| Opportunities for innovation: Building on the success of lipid nanoparticle vaccines. | Curr Opin Colloid Interface Sci | 2021 | 34093062 | PubTator, text mining | PubMed |
| Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. | J Hematol Oncol | 2021 | 34090506 | PubTator, text mining | PubMed |
| Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor. | Commun Biol | 2021 | 34079037 | PubTator, text mining | PubMed |
| Oxidized low-density lipoprotein stimulates dendritic cells maturation via LOX-1-mediated MAPK/NF-κB pathway. | Braz J Med Biol Res | 2021 | 34076144 | PubTator, text mining | PubMed |
| Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease. | Vaccines (Basel) | 2021 | 34073261 | PubTator, text mining | PubMed |
| Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity. | Cancers (Basel) | 2021 | 34073106 | PubTator, text mining | PubMed |
| Cord-Blood-Derived Professional Antigen-Presenting Cells: Functions and Applications in Current and Prospective Cell Therapies. | Int J Mol Sci | 2021 | 34072923 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma-Infiltrating CD3low Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players. | Curr Issues Mol Biol | 2021 | 34071865 | PubTator, text mining | PubMed |
| Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review. | Biomedicines | 2021 | 34066608 | PubTator, text mining | PubMed |
| Recent Progress in Dendritic Cell-Based Cancer Immunotherapy. | Cancers (Basel) | 2021 | 34065346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4065/papers?page=22